Tealwood Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Tealwood Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Sell	2,338 -4	-0.2%	-$2.72K	0.56%	92
2026 Q1	$1.81M	Buy	2,342 +13	+0.6%	+$9.95K	0.82%	54
2025 Q4	$1.8M	Sell	2,329 -5	-0.2%	-$3.4K	0.81%	58
2025 Q3	$1.31M	Sell	2,334 -38	-2%	-$21.5K	0.53%	98
2025 Q2	$1.25M	Buy	2,372 +637	+37%	+$356K	0.55%	96
2025 Q1	$1.1M	Sell	1,735 -5	-0.3%	-$3.44K	0.51%	100
2024 Q4	$1.24M	Buy	1,740 +4	+0.2%	+$3.36K	0.51%	97
2024 Q3	$1.82M	Buy	+1,736	New	+$1.93M	0.8%	50
2024 Q2	–	Sell	-1,731	Closed	-$1.67M	–	99
2024 Q1	$1.67M	Sell	1,731 -17	-1%	-$16.2K	0.75%	58
2023 Q4	$1.53M	Sell	1,748 -25	-1%	-$20.6K	0.73%	60
2023 Q3	$1.46M	Buy	1,773 +32	+2%	+$25.1K	0.75%	58
2023 Q2	$1.25M	Sell	1,741 -8	-0.5%	-$6.17K	0.61%	80
2023 Q1	$1.44M	Sell	1,749 -679	-28%	-$512K	0.73%	54
2022 Q4	$1.75M	Sell	2,428 -132	-5%	-$97.4K	0.92%	31
2022 Q3	$1.76M	Sell	2,560 -36	-1%	-$22.7K	0.95%	30
2022 Q2	$1.53M	Sell	2,596 -61	-2%	-$39.7K	0.76%	42
2022 Q1	$1.86M	Sell	2,657 -29	-1%	-$18.3K	0.79%	39
2021 Q4	$1.7M	Sell	2,686 -199	-7%	-$122K	0.68%	60
2021 Q3	$1.75M	Buy	+2,885	New	+$1.79M	0.71%	49
2021 Q1	$1.1M	Buy	2,321 +41	+2%	+$20K	0.44%	109
2020 Q4	$1.1M	Buy	+2,280	New	+$1.23M	0.52%	96

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Tealwood Asset Management's REGN Position: Q2 2026 in Review

Tealwood Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 0.17% in Q2 2026, selling an estimated $2.72K and leaving 2,338 shares worth $1.46M. The position accounts for 0.56% of the portfolio, ranked #92.

Tealwood Asset Management first reported a position in REGN in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.86M in Q1 2022. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Tealwood Asset Management held 2,338 shares of Regeneron Pharmaceuticals worth $1.46M as of Q2 2026.
Tealwood Asset Management sold 4 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
Regeneron Pharmaceuticals made up 0.56% of Tealwood Asset Management's portfolio in Q2 2026, its #92 holding.
Tealwood Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
Tealwood Asset Management's Regeneron Pharmaceuticals position peaked at $1.86M in Q1 2022.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Tealwood Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.